Shanmugam P. Selvam

Shanmugam P. Selvam, Ph.D. has a diverse work experience spanning various roles and industries. Shanmugam is currently working at NextCure, Inc. as an Associate Director Business Development, a position they have held since January 2022. Prior to this, they worked as a Business Development Manager at NextCure from December 2020 to December 2021.

Before joining NextCure, Dr. Selvam worked at the MUSC Foundation for Research Development. Shanmugam held the position of Technology Transfer Associate- Business Development and Licensing from January 2018 to November 2020. In this role, they were responsible for evaluating technologies, analyzing intellectual property landscapes, and filing patent applications. Shanmugam also played a key role in managing diligence and term sheet negotiations, resulting in the execution of license agreements with biotechnology companies and startups. Dr. Selvam demonstrated deep product and market knowledge in immuno-oncology and other therapeutic technologies, and facilitated alliance management through the execution of license deals.

Dr. Selvam began their research career at the Medical University of South Carolina (MUSC) in 2008. Shanmugam first served as a Postdoctoral Fellow from December 2013 to December 2017. During this time, they published several research papers in top-tiered journals and collaborated with scientists across institutions. Shanmugam also demonstrated leadership and team management skills by mentoring undergraduate and graduate students. Prior to their postdoctoral fellowship, Dr. Selvam completed their Ph.D. at MUSC from July 2008 to December 2013. Shanmugam'sdissertation research focused on discovering a novel mechanism of lipid binding that stabilized the Telomerase oncoprotein in lung cancer. Shanmugam'swork was published in prestigious journals, including Science Signaling, and received special commentary in Science magazine. Shanmugam was also awarded the Edith Peng award for research excellence.

Dr. Selvam's earlier work experience includes a role as a Research Officer (Project Manager) at Shasun. From October 2003 to June 2008, they played a pivotal role in the development, purification, and analytical method development for various recombinant proteins. Shanmugam successfully led the process development for Lifokinase™, which was marketed in India for acute myocardial infarction. Shanmugam also contributed to the technology transfer and completion of toxicology and preclinical trials for Lifokinase™ and recombinant interferon alpha.

Overall, Dr. Selvam's work experience demonstrates their expertise in business development, technology transfer, intellectual property management, and scientific research. Shanmugam has been involved in various aspects of the biotechnology industry, including licensing agreements, alliance management, and process development.

Shanmugam P. Selvam, Ph.D. has a diverse education history. In 1998, they earned a Bachelor of Science (B.Sc.) degree in Biochemistry from the University of Madras. Shanmugam then pursued a Master of Science (M.Sc.) degree in Industrial Biotechnology from Bharathiar University, which they completed in 2001.

In 2008, Shanmugam enrolled at the Medical University of South Carolina to further their education. Shanmugam dedicated five years to their studies, ultimately earning a Doctor of Philosophy (PhD) degree in Biochemistry and Molecular Biology in 2013.

Continuing their intellectual development, in 2019, Shanmugam obtained a CORe Credential of Readiness from Harvard Business School Online. This provided him with a strong foundation in business concepts and skills.

Additionally, they have acquired various certifications to enhance their knowledge and qualifications. In 2019, Shanmugam completed a course on Mergers & Acquisitions through LinkedIn. Shanmugam also obtained a certificate in Introduction to Marketing from the Wharton School of Business through Coursera Course Certificates in 2017.

With this diverse educational background and additional certifications, Shanmugam P. Selvam, Ph.D. has developed a strong foundation in both scientific and business disciplines.